ES2527504T3 - Antiviral method - Google Patents

Antiviral method Download PDF

Info

Publication number
ES2527504T3
ES2527504T3 ES11174632.7T ES11174632T ES2527504T3 ES 2527504 T3 ES2527504 T3 ES 2527504T3 ES 11174632 T ES11174632 T ES 11174632T ES 2527504 T3 ES2527504 T3 ES 2527504T3
Authority
ES
Spain
Prior art keywords
policuaternio
polyquaternium
composition
alcoholic composition
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11174632.7T
Other languages
Spanish (es)
Inventor
Marcia Snyder
David R. Macinga
James W. Arbogast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Go-Jo Industries Inc
Original Assignee
Go-Jo Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/499,227 external-priority patent/US8119115B2/en
Priority claimed from US11/670,114 external-priority patent/US20070185216A1/en
Application filed by Go-Jo Industries Inc filed Critical Go-Jo Industries Inc
Application granted granted Critical
Publication of ES2527504T3 publication Critical patent/ES2527504T3/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Uso como desinfectante contra partículas de virus no envueltos seleccionados entre las familias Picornaviridae, Reoviridae, Caliciviridae, Adenoviridae y Parvoviridae de una composición alcohólica virucida, caracterizado por que la composición comprende un alcohol C1-6 y una cantidad de uno o más potenciadores que incluyen un donador de protones, y donde la composición alcohólica comprende además de un 0,02 a un 20% en peso de un oligómero o polímero catiónico, en base al peso total de la composición alcohólica, donde el oligómero o polímero catiónico es uno de policuaternio-2, policuaternio-4, policuaternio-5, policuaternio-6, policuaternio-7, policuaternio-10, policuaternio-11, policuaternio-16, policuaternio-22, policuaternio-24, policuaternio-28, policuaternio-32, policuaternio-37, policuaternio-39, policuaternio-42, policuaternio-43, policuaternio-44, policuaternio-46, policuaternio-47, policuaternio-51, policuaternio-53, policuaternio-55, policuaternio-57, policuaternio-58, policuaternio-59, policuaternio-60, policuaternio-63, policuaternio-64, policuaternio-65, policuaternio-68 o sus mezclas, y la composición comprende al menos un 50% en peso de alcohol C1-6 en base al peso total de la composición alcohólica, excluyendo los métodos terapéuticos de tratamiento del cuerpo humano o animal.Use as a disinfectant against non-enveloped virus particles selected from the families Picornaviridae, Reoviridae, Caliciviridae, Adenoviridae and Parvoviridae of a virucidal alcoholic composition, characterized in that the composition comprises a C1-6 alcohol and an amount of one or more enhancers that include a proton donor, and where the alcoholic composition also comprises 0.02 to 20% by weight of a cationic oligomer or polymer, based on the total weight of the alcoholic composition, where the cationic oligomer or polymer is one of polyquaternium 2, policuaternio-4, policuaternio-5, policuaternio-6, policuaternio-7, policuaternio-10, policuaternio-11, policuaternio-16, policuaternio-22, policuaternio-24, policuaternio-28, policuaternio-32, policuaternio-37, policuaternio-39, policuaternio-42, policuaternio-43, policuaternio-44, policuaternio-46, policuaternio-47, policuaternio-51, policuaternio-53, policuaternio-55, policuaternio-57, policua ternio-58, polyquaternium-59, polyquaternium-60, polyquaternium-63, polyquaternium-64, polyquaternium-65, polyquaternium-68 or mixtures thereof, and the composition comprises at least 50% by weight of C1-6 alcohol based on Total weight of the alcoholic composition, excluding therapeutic methods of treatment of the human or animal body.

Description

imagen1image 1

imagen2image2

imagen3image3

imagen4image4

imagen5image5

imagen6image6

imagen7image7

imagen8image8

imagen9image9

imagen10image10

imagen11image11

imagen12image12

imagen13image13

imagen14image14

imagen15image15

imagen16image16

imagen17image17

imagen18image18

imagen19image19

Claims (1)

imagen1image 1
ES11174632.7T 2006-02-09 2007-02-07 Antiviral method Active ES2527504T3 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US670114 1991-03-15
US77174406P 2006-02-09 2006-02-09
US771744P 2006-02-09
US499227 2006-08-07
US11/499,227 US8119115B2 (en) 2006-02-09 2006-08-07 Antiviral method
US11/670,114 US20070185216A1 (en) 2006-02-09 2007-02-01 Antiviral method

Publications (1)

Publication Number Publication Date
ES2527504T3 true ES2527504T3 (en) 2015-01-26

Family

ID=47110757

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11174632.7T Active ES2527504T3 (en) 2006-02-09 2007-02-07 Antiviral method

Country Status (8)

Country Link
KR (1) KR101319151B1 (en)
CN (1) CN102973540B (en)
DK (1) DK2471559T3 (en)
ES (1) ES2527504T3 (en)
HK (2) HK1129608A1 (en)
IN (1) IN2014DN07845A (en)
MY (1) MY148678A (en)
PT (1) PT2471559E (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201410510D0 (en) * 2014-06-12 2014-07-30 Fantex Ltd Liquid Antimicrobial
KR102200507B1 (en) 2019-12-11 2021-01-08 주식회사 아워홈 Composition for Antiviral disinfectants
CN111513067A (en) * 2020-04-29 2020-08-11 江苏斯微特医药科技有限公司 Compound alcohol-oxygen-sugar disinfectant
CN116056570A (en) * 2020-08-20 2023-05-02 大日本除虫菊株式会社 Virus inactivating agent composition, method for enhancing virus inactivating efficacy, and method for inactivating virus
KR20220030428A (en) 2020-08-31 2022-03-11 주식회사 원우정밀 Apparatus in the type of fine spraying for sterilizing and disinfecting
US20220135904A1 (en) * 2020-11-02 2022-05-05 Microban Products Company Use of ethoxylated alcohols to impede enveloped viral spread

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3702983A1 (en) * 1986-06-09 1987-12-10 Henkel Kgaa DISINFECTANT AND THEIR USE FOR SKIN AND MUCUS SKIN DISINFECTION
MXPA03007748A (en) * 2001-02-28 2004-03-16 Thomas W Konowalchuk Virucidal compositions.

Also Published As

Publication number Publication date
KR20120102141A (en) 2012-09-17
MY148678A (en) 2013-05-31
CN102973540B (en) 2015-08-19
DK2471559T3 (en) 2015-01-12
CN102973540A (en) 2013-03-20
HK1183623A1 (en) 2014-01-03
HK1129608A1 (en) 2009-12-04
IN2014DN07845A (en) 2015-07-10
KR101319151B1 (en) 2013-10-17
PT2471559E (en) 2014-12-09

Similar Documents

Publication Publication Date Title
ES2527504T3 (en) Antiviral method
UY30481A1 (en) SUBSTITUTED ISOXAZOLINS, PHARMACCUTIC COMPOSITIONS CONTAINING THE SAME, PREPARATION METHODS AND USES.
ES2526555T3 (en) Fungicidal composition and method to control plant diseases
CL2009002207A1 (en) Compounds derived from 3-hydroxy-5- (9h-purin-9-yl) tetrahydrofuran-2-yl, an inhibitor of the replication of arn-dependent viral arn; pharmaceutical composition; use for the treatment of hepatitis c.
UY32923A (en) POLYCHYCLICAL COMPOUNDS AS ANTAGONISTS OF THE LISOPHOSPHATIDIC ACID RECEPTOR
ECSP13013019A (en) 2'-substituted nucleoside derivatives and methods of their use for the treatment of viral diseases
ECSP11011113A (en) VEGF-R2 PIRIDYLOXI-INDOLES INHIBITORS AND USE OF THE SAME FOR THE TREATMENT OF DISEASES
AR054064A1 (en) COMPOSITION WITH ACTIVE PHARMACEUTICAL INGREDIENT BASED ON CANABINOID FOR IMPROVED DOSE FORMS
CR11201A (en) DERIVATIVES OF PIRIMIDINE TRISUSTITUIDA FOR THE TREATMENT OF PROLIFERATIVE DISEASES
AR072072A1 (en) SPECIFIC PEPTIDES OF THE MELANOCORTINE RECEPTOR FOR THE TREATMENT OF OBESITY / 669
EA202091999A2 (en) APPLICATION OF DPP IV INHIBITORS
CO6751268A2 (en) Novel cyclic azabenzimidazole derivatives useful as antidiabetic agents
CO6351742A2 (en) ORGANIC COMPOUNDS FOR WOUND CICATRIZATION
CR11200A (en) PIRIMIDINE MORFOLINE DERIVATIVES USED IN DISEASES RELATED TO MTOR QUINASA AND / OR P13K
CR9722A (en) DERIVATIVES OF BENZILPIPERAZINA AND ITS MEDICAL USE
PE20090938A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING A BENZENE DERIVATIVE SUBSTITUTED WITH GLUCOPYRANOSIL
DOP2011000094A (en) PHARMACEUTICAL FORMULATION 514
PA8638001A1 (en) HETEROARIL-Y FENILSULFAMOILO SUBSTITUTED COMPOUNDS
UY29639A1 (en) AMIDAS REPLACED WITH HETEROARILO UNDERSTANDING AN INSATURED OR CYCLIC LINKER GROUP, AND ITS USE AS PHARMACEUTICAL PRODUCTS
CL2008000445A1 (en) METHOD FOR THE PROPHYLAXIS AND THE TREATMENT OF A SUBCLINICAL INFECTION BY SWINE CIRCOVIRUS TYPE 2 (PCV2) IN AN INDIVIDUAL ANIMAL OR AN ANIMAL GROUP THAT INCLUDES TO ADMINISTER AN ANTIGEN OF PCV2; USE OF THE PCV2 ANTIGEN FOR THE PROFILAXIS OF A
AR077125A1 (en) PHARMACEUTICAL COMBINATIONS USEFUL TO TREAT HCV
UY28726A1 (en) N-CYCLHEXILIMIDAZOLINONAS SUBSTITUTES.PROCEDIMIENTOS FOR ITS PREPARATION AND ITS USE AS MEDICATIONS.
PE20070333A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING AGOMELATIN FOR THE TREATMENT OF SLEEP DISORDERS IN DEPRESSED PATIENTS
ECSP088527A (en) 3-AMINOCICLOPENTANOCARBOXAMIDS AS CHEMIOKIN RECEPTORS MODULATORS
ECSP11011124A (en) CCR2 4-AZETIDINIL-1-HETEROARIL-CICLOHEXANOL ANTAGONISTS